30-50 Million J&J Vaccine Doses Found Idle in Baltimore Plant
An estimated 30 million to 50 million doses of Johnson & Johnson’s Covid-19 vaccine are sitting idly in Emergent BioSolutions’ Baltimore facility waiting to be distributed.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
Novartis Under New DOJ Scrutiny Over Potential Kickback Allegations
/in NovartisIn the company’s third-quarter 2021 financial earnings report, Novartis noted that the Swiss drugmaker is the subject of a U.S. Department of Justice (DOJ) inquiry over the marketing and pricing of Entresto during the past five years, receiving a Civil Investigative Demand from the government.
Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022
/in MerckMerck & Co. Inc. on Oct. 28 said the company’s experimental Covid-19 drug could bring in between $5 billion and $7 billion in sales through the end of 2022, assuming the antiviral drug molnupiravir gains U.S. authorization in December 2021.
WHO, partners seek $23.4 billion for new COVID-19 war chest
/in World Health OrganizationThe World Health Organization (WHO) and other aid groups on Oct. 28 appealed to leaders of the world’s 20 biggest economies to fund a $23.4 billion plan to bring Covid-19 vaccines, tests and drugs to poorer countries in the next year.
The Ad Council Appoints 18 New Members to Board of Directors
/in Ad Council, Appointments, Business, Healthcare Communications Networks, Marketing & Advertising, Nonprofit, People on the MoveThe Ad Council, America’s leading non-profit organization dedicated to using the power of communications to drive social change, elected 18 new members to the Board of Directors during its fall meeting held virtually October 27.
Takeda Snaps Up Partner GammaDelta to Bolster Oncology Pipeline
/in Acquisitions, Acute Myeloid Leukemia (AML), Business, Clinical Trials, Divestments, Gamma Delta T Cells, Oncology, Partnerships, Product Pipelines, R&D, Solid Tumors, TakedaFour years after partnering with GammaDelta Therapeutics to develop therapies for solid tumors, Takeda Pharmaceutical pulled the trigger and exercised its option to acquire the London-based company.
U.S. CDC panel to discuss COVID-19 shots for younger kids on Nov. 2
/in Advisory Committees, BNT162b2 (Pfizer and BioNTech), CDC, COVID-19 shots, COVID-19 Vaccines, FDA, KidsAn advisory panel of the U.S. Centers for Disease Control and Prevention will meet on Nov. 2 to discuss the use of Covid-19 vaccines in children aged between 5 and 11 years.
Breakthrough infections can lead to long COVID; genes may explain critical illness in young, healthy adults
/in Breakthrough COVID-19, Fat Cells, Genes, Immune Response, Medical Journals, Messenger RNA (mRNA) Vaccines, Obesity, Oxford University, Pregnancies, R&D, Science Translational MedicineA new study shows the persistent syndrome of Covid-19 after-effects known as long Covid can develop after “breakthrough” infections in vaccinated people. Other new findings suggest a gene that helps the coronavirus reproduce itself might contribute to life-threatening Covid-19 in young, otherwise healthy people.
COVID infections, deaths dropping across the Americas – health agency
/in Caribbean, Central America, COVID-19 Deaths, COVID-19 Infections, Cuba, North America, Pan-American Health Organization (PAHO), Paraguay, South AmericaCovid-19 is slowly retreating across most of North, Central and South America, the Pan American Health Organization (PAHO) said on Oct. 27, reporting that last week the continent’s death and infection figures were the lowest in over a year.
AbelsonTaylor Elevates Beth Carik to Senior Vice President of Human Resources
/in Appointments, Healthcare Communications Agencies, Marketing & Advertising, People on the Move, PromotionsHealth and wellness advertising agency AbelsonTaylor promoted Beth Carik to senior vice president of human resources.